Alert: lamotrigine Desitin 10mg/ml oral suspension

Desitin Pharma UK Ltd is recalling all batches of lamotrigine Desitin 10mg/ml oral suspension as a precautionary measure.

This is due to testing which has revealed the potential for some doses to have incorrect amounts of the active ingredient (lamotrigine).

Healthcare professionals

Stop supplying the impacted batch immediately. Quarantine all remaining stock and return it to your supplier/MAH using your supplier’s approved process.

Patients should be advised not to stop their medication as this may cause seizures to start again or happen more often or last longer than before.

1. Pharmacists should identify and immediately contact all patients who have been dispensed the impacted batches and ask them to confirm if they have remaining stock within their possession. If batch traceability information is not available, all patients dispensed this product from 07 May 2024 should be contacted. Patients and carers should be reminded that suddenly stopping an epilepsy medicine may cause seizures to start again or happen more often or last longer than before.

If the pharmacist identifies any patients with an impacted product, they should, in the first instance, contact the patient’s GP or prescriber and discuss alternative lamotrigine treatment for the patient. As patients may require monitoring, other clinicians and healthcare professionals may need to be involved.

MHRA alert